RAYSUNA Trademark

Trademark Overview

On Wednesday, November 10, 2021, a trademark application was filed for RAYSUNA with the United States Patent and Trademark Office. The USPTO has given the RAYSUNA trademark a serial number of 97117718. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, May 15, 2024. This trademark is owned by Alpha Cognition Canada Inc.. The RAYSUNA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of Alzheimer disease
raysuna

General Information

Serial Number97117718
Word MarkRAYSUNA
Filing DateWednesday, November 10, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, May 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of Alzheimer disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlpha Cognition Canada Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrisco, TX 75036
Party NameAlpha Cognition Canada Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC, V6B6L2
CA

Trademark Events

Event DateEvent Description
Thursday, July 14, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Saturday, November 13, 2021NEW APPLICATION ENTERED
Wednesday, November 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 22, 2022ASSIGNED TO EXAMINER
Monday, August 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, May 1, 2023SOU EXTENSION 1 GRANTED
Tuesday, November 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 1, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 1, 2023SOU EXTENSION 1 FILED
Monday, November 13, 2023SOU EXTENSION 2 FILED
Wednesday, May 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 2 GRANTED
Thursday, May 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 15, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 15, 2024SOU EXTENSION 3 GRANTED
Wednesday, May 15, 2024SOU EXTENSION 3 FILED
Friday, June 21, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 21, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 21, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

raysuna alzheimer disease treatment prevention preparations pharmaceutical